Unlocking neurodivergent participation: Nine ways to create patient-centric clinical trials

At Fortrea, we're dedicated to transforming this landscape by championing approaches that empower neurodivergent participants to fully engage in clinical research.

Clinical trial Site Support Services : a solution for increasing research demand

OncoInsights

Physicians usually focus on the latest scientific advances that are relevant to our clinical practice.

Harnessing the power of real-world data to drive more effective decision making in oncology clinical trials

How real-world data helps drug developers design and execute more efficient and adaptive compex trials.

Bridging the translation gap in immuno-oncology

The path from preclinical to clinical success is reviewed pragmatically in this article.

Realizing the potential of decentralized clinical trials in oncology

Considering opportuities to decentralize oncology trials or parts of trials can help patient recruitment and participation.

Designing patient-centric ePROs to reduce patient burden and promote study compliance in a multinational Phase III oncology trial

Designing a patient-centric approach in a Phase III NSCLC Phase III trial.

San Francisco Bay Area biotech advances Phase I-II cancer immunotherapy trial with Fortrea

Rigorous site selection and recruitment to accomplish patient enrollment with extensive inclusion/exclusion criteria.

Extreme customer service: complex oncology patient support program consolidation

Delivering seamless transition of product data from another vendor

How Fortrea brought an agile partnership approach to delivering a new oncology model

Fortrea delivery of two trials in parallel that grew to suite of studies.